Shaddari will be joining 16 other startups specialized in AI+ Life Sciences as the winners of the C2CAN Canada-China acceleration network to meet innovation clusters and tier 1 investors in the cities of Shenzhen, Hong kong, Guangzhou and Beijing.
Precision Medicine
